Coxsackie B1, B3, B4, B5 Nosodes
Generic Name: coxsackie b1, b3, b4, b5 nosodes
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS A2 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS A7 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B1 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B3 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B4 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B5 (10 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS A2 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS A7 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B1 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B3 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B4 (10 [hp_M]/mL); HUMAN COXSACKIEVIRUS B5 (10 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Levophed(r) Norepinephrine Bitartrate
levophed(r) norepinephrine bitartrate
DESCRIPTION Norepinephrine (sometimes referred to as l-arterenol/Levarterenol or l-norepinephrine) is a sympathomimetic amine which differs from epinephrine by the absence of a methyl group on the nitrogen atom.
Curl Moisture Anti-dandruff Conditioner
curl moisture anti-dandruff conditioner
Purpose Anti-dandruff
Eplerenone
eplerenone
Aldosterone Antagonist [EPC]
Mineralocorticoid receptor antagonist indicated for heart failure post-MI survival improvement and hypertension treatment to reduce cardiovascular event risk.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.